CD30 in myeloid malignancies: hitting the bull's-eye with an available dart

Leuk Lymphoma. 2013 Apr;54(4):679-80. doi: 10.3109/10428194.2012.728703. Epub 2012 Sep 28.

Authors

Ashkan Emadi¹, Judith E Karp

Affiliation

¹ University of Maryland, School of Medicine, Marlene & Stewart Greenebaum Cancer Center, Leukemia & Hematologic Malignancies, Baltimore, MD, USA. aemadi@umm.edu

PMID: 22966972
DOI: 10.3109/10428194.2012.728703

No abstract available

Publication types

Comment

MeSH terms

Humans
Ki-1 Antigen / metabolism*
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / metabolism*
Leukocytosis / genetics*
Mutation*
fms-Like Tyrosine Kinase 3 / genetics*

Substances

Ki-1 Antigen
fms-Like Tyrosine Kinase 3